MALIGNANT MELANOMA. Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention.

Slides:



Advertisements
Similar presentations
Skin Pathology, Case 3 40 year-old female with no significant past medical history presents with a 1 cm pigmented lesion on the back. The borders are irregular.
Advertisements

Heather Verity Audience: High School Students Skin Cancer.
MELANOMA.
SKIN CANCER.
Skin Lesion James Warneke, MD University of Arizona.
Malignant melanoma melanoma. Malignant melanoma -malignant tumor arising from melanocytes -tendency to early lymphogenic and haematogenic metastasing.
MALIGNANT EYELID TUMOURS
By Tord Høgsand and Magnus Sundstrøm
Sun safety Lesley Pallett Workforce Health & Wellbeing Specialist Advisor and Ian Murray Dermatology Nurse.
Psoriasis & Skin Cancer
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
Cory Klinger Korey Kainec Ian Behra. What is Melanoma?? Melanoma is a malignant tumor. If not found early, melanoma can ne very dangerous. It is responsible.
Casey Bower. What is Melanoma? Melanoma is the most common cancer in the United States and the most dangerous form of skin cancer, melanoma begins in.
 Melanoma is a cancer that develops in melanocytes, the pigment cells present in the skin. It can be more serious than the other forms of skin cancer.
Melanoma Hai Ho, M.D. Department of Family Practice.
Your Skin J. C. DiGiacomo, M.D., FACS Department of Surgery CentraState Medical Center.
Melanoma By Libby Walker, Jessica Morehouse, Rebecca Jurovich, Ashley Leonard.
A Tan to Die For? Dan Magrill Taz Singh Laura Tincknell.
1 PowerPoint ® to accompany Second Edition Ramutkowski  Booth  Pugh  Thompson  Whicker Copyright © The McGraw-Hill Companies, Inc. Permission required.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
SIAscope Training Course Micro-architecture of skin lesions.
Neoplasms (Growths). Neoplasms 1. Moles Pigmented Moles Benign growth of Melanocytes.
SKIN CANCER KARINA PARR, MD RONALD GRIMWOOD, MD KARA KENNEY.
Cutaneous Malignancies
Burns Burns are categorized by severity as first, second, or third degree. First degree burns are similar to a painful sunburn, causing redness and swelling.
Chapter 4.  Basal Cell Carcinoma  Squamous Cell Carcinoma  Malignant Melanoma  Kaposi Sarcoma.
S KIN C ANCER Kathy Sheriff, RN, BSN. S KIN C ANCER One in five Americans Crucial risk factor—over exposure to UV radiation in sunlight Other cases, frequent.
Meet Joe. Facts About Joe Joe lives in California and works for a big technology corporation. Joe likes to spend all of his free time at the beach. He.
Skin Cancers Pages
DR. OLGA WATKINS November Outline Of Presentation Common Skin Lesions, Benign And Malignant Assessment Of Pigmented Lesion Points to take home.
FOH Presents… Skin Cancer
 Causes and symptoms  3 main types of melanoma  Diagnosis  Treatments  Tips on prevention  Conclusion.
Basal Cell Carcinoma. Basal Cell Carcinoma Basal Cell Carcinoma.
© 2005, Wellsource, Inc. Melanoma Recognizing Skin Cancer Prepared by Don Hall, DrPH, CHES Wellsource Inc.
Skin tumors. Melanocytic naevi Melanocytic naevi are normal, benign proliferations of melanocytes. Although the risk of a naevus evolving into a melanoma.
Better Health. No Hassles. Skin Cancer Abnormal growth of skin cells On skin exposed to the sun Can occur in other areas though !!!! 3 types Basal cell.
November 13, 2007 Chapter: 31 Title: Noninfectious Diseases and Disabilities Lesson : 2 Title: Skin Cancer Grade Level: High school freshman health class.
Melanoma. Remember: melanoma ≠ myeloma 1. What, in general, is a melanoma? A tumor of melanin-forming cells (melanocytes from the basal layer of the.
Cancer Invasive cellular neoplasm that has the capability of spreading throughout the body or body parts; uncontrolled cell growth.
Skin Cancer Anatomy & Physiology Mrs. Halkuff. Metastasize (Metastasis): Spreading of cancer Benign: A non- cancerous tumor Malignant: A cancerous tumor.
Mark Browning, M.D. IUSME.  Intermittent high exposure to the sun is a major risk  Other risk include a family history and an increased number.
Melanoma Raising Awareness. Quick Facts About 68,720 people were diagnosed with melanoma in ,650 died of melanoma Melanoma accounts for 3% of skin.
Melanoma. Skin Cancer  Most common type of cancer in the United States  The Skin is one of the most important parts of your body Information provided.
MELANOMA Stephen G. Mallette, D.O. Athens, Alabama.
The Integumentary System
Disorders of Melanocytes Melanoma
“Malignant skin tumors”
MALIGNANT MELANOMA.
INFECTIONS Allergies, Fungal, Bacterial, Viral, Infection, Inflammation, and Genetic.
What you need to know to prevent it
Seborrheic keratosis eyelid
Skin Cancer A Colorado Concern.
Atypical and malignant pigmented lesions
SKIN CANCER NOTES.
8th & 7th Grade Objective 1.2.
Advanced Biology Burns Skin Cancer.
Pathophysiology Unregulated cell growth and uncontrolled cell division result in the development of neoplasm.  Basal cell keratinization causes basal cells,
Skin Cancer and Burns.
Lecture #2 Common Skin Lesions and Skin Malignancies
Principles and Practice of Radiation Therapy
Test yourself with these suspicious lesions
Malignant Melanoma Aalayis Suggs.
Presentation transcript:

MALIGNANT MELANOMA

Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention

Skin: Epidermis - Melanocytes Melanocytes: –In stratum basale –Pale “halo” of cytoplasm –Neural crest –Produce melanin and pass it on to nearby keratinocytes –Melanin covers nuclei of nearby keratinocytes –Skin colour depends on melanocytes activity, rather than the number present

MALIGNANT MELANOMA A tumour arising from melanocytes of the basal layer of the epidermis Less commonly – uveal tract (eye) and meningeal membranes

AETIOLOGY The cause is unknown. Excessive exposure to sunlight Genetic predisposition

RISK FACTORS FOR MELANOMA Large numbers of benign naevi Clinically atypical naevi Severe sunburn Early years in a tropical climate Family history of MM

Clinical features Occur anywhere on the skin –Females (commonest is lower leg) –Males ( back). Early melanoma is pain free. The only symptom if present is mild irritation or itch.

AIDS IN CLINICAL DIAGNOSIS GLASGOW SYSTEM Major: Change in size Irregular pigment Irregular outline Minor: Diameter >6mm Inflammation Oozing/bleeding Itch/altered sensation AMERICAN ‘ABCDE’ SYSTEM Asymmetry Border Colour Diameter Evolution

Evolving; a mole or skin lesion that looks different from the rest or is changing in size, shape, or color

TYPES OF MELANOMA Superficial spreading Malignant melanoma Nodular melanoma Letingo maligna melanoma Acral malanoma

SUPERFICIAL SPREADING The most common type of MM in the white-skinned population – 70% of cases Commonest sites – lower leg in females and back in males In early stages may be small, then growth becomes irregular

NODULAR Commoner in males Trunk is a common site Rapidly growing Usually thick with a poor prognosis Black/brown nodule Ulceration and bleeding are common

ACRAL LENTIGINOUS MELANOMA In white-skinned population this accounts for 10% of MMs, but is the commonest MM in nonwhite-skinned nations Found on palms and soles Usually comprises a flat lentiginous area with an invasive nodular component

SUBUNGAL MELANOMA Rare Often diagnosed late – confusion with benign subungal naevus, paronychial infections, trauma Hutchinson’s sign – spillage of pigment onto the surrounding nailfold

LENTIGO MALIGNA MELANOMA Occurs as a late development in a lentigo maligna Mainly on the face in elderly patients May be many years before an invasive nodule develops

DDx Superficial spreading melanomas Benign melanocytic naevi. Nodular melanomas Vascular tumor Histiocytoma Latingo maligna melanoma Seborrhic keratoses

PROGNOSTIC VARIABLES The Breslow thickness is the single most important prognostic variable (distance in mm of the furthest tumour cell from the basal layer of the epidermis) Breslow depth 5 year survival In situ95-100% <1mm95-100% 1-2mm80-96% 2.1-4mm60-75% >4mm50%

Scalp lesions worse prognosis, then palms and soles, then trunk, then extremeties Younger women appear to do better than either men at any stage or women over 50 Ulceration of the tumour surface is a high risk factor

MANAGEMENT Surgical resection of tumour MOHS technique Lymph node dissection Chemotherapy Radiotherapy Immunotherapy

Prevention Reduce risk factor exposure: Covering up (sunscreen, sunglasses, clothes) Avoidance (less time in sun) Screening (possibly feasible)